Action4Canada - August 22, 2021


Canada's Role in the Development of the SARSCoV2 Jab

Hosted by
Tanya Gaw
Mentioned
Trudeau Pfizer Moderna Thomas Madden Hill
Market Manipulation and Felony Crimes Maxime Bernier

Episode Stats


Length

8 minutes

Words per minute

133.58

Word count

1,080

Sentence count

32


Summary

Summaries generated with gmurro/bart-large-finetuned-filtered-spotify-podcast-summ .

In this episode, I discuss the role that Canada played in developing and commercializing one of the world's most important biological weapons: the M.O.V. (memc-vaccine) delivery system for treating viruses such as HIV/AIDS, SARS, and other viral diseases.

Transcript

Transcript generated with Whisper (turbo).
Hosts, guests, and mentioned names generated with spaCy (en_core_web_sm), reconciled against Wikidata.
00:00:00.560 And according to Pfizer, we have what they refer to in their own documents as an acceptable death rate.
00:00:09.140 I don't know how many of you can sit with that statement, but the notion that there is something called an acceptable death rate is something I find morally repugnant.
00:00:20.380 But I find more interesting than that, Canada's role in this, which has achieved almost no fundamental coverage in any media or even in the counterculture media, and most Canadians don't realize that Canada itself, and not just Canada, but specifically the University of British Columbia, beginning in 2005, realized that if it was going to be relevant in the biotech space,
00:00:50.380 it had to be the country, and it had to be the research hotbed for establishing the delivery mechanism whereby mRNA vaccines could be developed.
00:01:02.180 The University of British Columbia, working in partnership with INEX Pharmaceuticals in 2005, developed the lipid nanoparticle technology that ultimately became the basis of the formation of a company in British Columbia called Techmera Pharmaceuticals.
00:01:18.140 In 2009, Techmera had a very interesting set of challenges, and this was commensurate with the 2008 declaration by the World Health Organization that the coronavirus was in fact eradicated as a condition associated with SARS.
00:01:35.820 And because of the lack of funding in 2008, both Canada and the United States struggled with the fact that they had developed a technology that was supposed to be for a vaccination of coronavirus and for a number of other viral models.
00:01:52.100 But the problem was they ran out of funding, but the problem was they ran out of funding, and so there was a series of reorganizations, and in those reorganizations, two companies were formed, Arbutus Pharmaceuticals and Acuitus Pharmaceuticals.
00:02:05.300 Acuitus is the one that, unfortunately, the government of Canada has not told the citizens of Canada is the reason why both Moderna and Pfizer have the ability to deliver the current bioweapons program.
00:02:20.960 And I think most people would be shocked to find out that when you have the Prime Minister of Canada getting up in front of a camera in the spring of 2020 telling the world that the only way forward is to allegedly return to a new normal when there is a vaccine,
00:02:41.280 what Trudeau did not tell the public, what Trudeau did not tell the public was that he had a financial stake in the outcome of that being the selected pathway forward.
00:02:51.280 What he didn't tell the Canadian public was that Canada's blight on the moral record of what has been historically an amazingly wonderful set of innovations coming out of the Canadian research institutions and research laboratories,
00:03:09.460 in fact created the mechanism whereby you could take mRNA and inject it into a population and try to stabilize that injection.
00:03:18.620 The lipid nanoparticle technology that was developed and ultimately passed to Arbutus was the subject of a licensing agreement
00:03:26.460 that was made with Acuitous pharmaceuticals in British Columbia private company who conveniently had very little reporting requirements
00:03:35.400 and Acuitous misappropriated the lipid nanoparticle technology
00:03:41.080 and ultimately made it available to both BioNTech and Moderna.
00:03:46.620 It is absolutely critical for us to understand that without the Canadian contribution of the lipid nanoparticle technology from British Columbia,
00:03:56.640 we would have no meaningful response in the form of what's being called a vaccination and we would not have a bioweapons program.
00:04:06.880 That's a pretty important statement to make to an audience largely of Canadians.
00:04:10.820 And it would be very interesting to find out why it is that Trudeau has not admitted to the public
00:04:18.380 and has been unwilling to actually put into the public record the what we know to be at least billions of dollars of concessions.
00:04:29.740 And it could be, I mean, if we look at just Pfizer-BioNTech's own situation,
00:04:35.040 we know that in the case of Pfizer-BioNTech, that last quarter alone, somewhere between eight and nine billion dollars
00:04:44.200 came in the form of the revenue off of all of the interventions that are being sold off as coronavirus vaccines.
00:04:54.740 In the last quarter alone, this would place this tiny little British Columbia company,
00:05:00.080 which in 2009, people, was functionally owned by one person.
00:05:05.500 I mean, we need to kind of bear that in mind.
00:05:08.320 One person actually owned this company, Thomas Madden, who's the CEO of Acuitous.
00:05:15.360 In 2009, he was largely the sole owner of it.
00:05:19.860 He actually appropriated the technology in a labor dispute,
00:05:23.760 which functionally was a trade secret argument around this.
00:05:27.740 And when we actually look at what happened in 2016,
00:05:31.480 and this is a very important point, people.
00:05:33.680 In 2016, somebody in Canada knew that there was something going to happen
00:05:39.820 with this particular vaccine platform,
00:05:42.540 because in 2016,
00:05:45.960 Arbutus Pharmaceuticals and Acuitous Pharmaceuticals
00:05:49.220 got into litigation on whether or not
00:05:52.140 the license for the lipid nanoparticle technology
00:05:55.880 that Acuitous had from Arbutus
00:05:58.220 was, in fact, capable of being extended to other pathogens.
00:06:03.780 And in 2016, there was a significant amount of litigation
00:06:06.560 and the license that Acuitous had
00:06:09.920 to use lipid nanoparticle technology developed by Techmera,
00:06:14.600 developed by Arbutus,
00:06:16.220 the license was actually terminated in 2016.
00:06:19.620 That coincides with the weaponization of SARS-CoV-2.
00:06:26.580 Now, do we have, at this moment in time,
00:06:31.520 the written record of the evidence
00:06:33.380 of what we know was knowable?
00:06:36.540 The answer to that is no.
00:06:38.580 There is no public information that currently exists
00:06:42.120 that has been made in any format that any of us can access.
00:06:45.800 There's no public information to tell us
00:06:48.180 what precisely transpired in 2016,
00:06:51.760 which allowed this particular dispute to erupt
00:06:56.060 between these two Canadian firms,
00:06:57.900 all based in the history of Techmera.
00:07:01.600 But somewhere in 2016,
00:07:03.820 somebody knew that there was a lottery win to be had.
00:07:06.480 And my guess is that somewhere inside
00:07:09.860 of the Canadian health system
00:07:11.460 and somewhere inside NIAID
00:07:14.360 and the Vaccine Research Center
00:07:15.780 and somewhere inside the UNC Chapel Hill records,
00:07:18.980 we will find that the Trudeau government
00:07:23.640 was fully aware by at least 2018
00:07:27.800 that we were going to have a significant pandemic
00:07:33.800 requiring this core technology
00:07:36.460 to be unleashed on the world
00:07:39.060 courtesy of the Canadian collaboration
00:07:42.240 on lipid nanoparticles.
00:07:43.920 And there is no question
00:07:45.000 that by the time we get to 2019,
00:07:49.220 March specifically of 2019,
00:07:51.460 we know that Arbutus, Moderna,
00:07:55.140 Pfizer-BioNTech and others
00:07:56.520 were in fact working on a vaccine
00:07:59.700 for a respiratory pathogen.
00:08:01.100 And we know that information
00:08:02.080 because they amended their patent filings
00:08:03.920 to say exactly that.